PE3P has been used at a dosage of 40 to 80 mg by intramuscular injection once every 4 to 8 weeks in menopausal hormone therapy. Available forms PE3P has been available in the form of ampoules containing 50 to 80 mg in 1 or 2 mL aqueous solution.
Polyestriol phosphate
Polyestradiol phosphate
Estradiol diundecylate
Estradiol palmitate
Estriol glucuronide
Estriol sulfate glucuronide
Progestogen ester
Conjugated estriol